126 related articles for article (PubMed ID: 29324916)
1. A comparison of
Ololade K; Mokgoro NP; Lawal IO; Vorster M; Boshomane TG; Sathekge MM
Hell J Nucl Med; 2017; 20 Suppl():71-79. PubMed ID: 29324916
[TBL] [Abstract][Full Text] [Related]
2. CT Texture Analysis of Cervical Lymph Nodes on Contrast-Enhanced [
Kuno H; Garg N; Qureshi MM; Chapman MN; Li B; Meibom SK; Truong MT; Takumi K; Sakai O
AJNR Am J Neuroradiol; 2019 Mar; 40(3):543-550. PubMed ID: 30792253
[TBL] [Abstract][Full Text] [Related]
3. Defining Characteristics of Nodal Disease on PET/CT Scans in Patients With HIV-Positive and -Negative Locally Advanced Cervical Cancer in South Africa.
Minnaar CA; Baeyens A; Ayeni OA; Kotzen JA; Vangu MD
Tomography; 2019 Dec; 5(4):339-345. PubMed ID: 31893232
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG-PET/CT imaging of uterine cervical cancer recurrence in women with and without HIV infection.
Lawal IO; Ololade KO; Popoola GO; Ankrah AO; Vorster M; Maes A; Mokgoro NP; van de Wiele C; Sathekge MM
Q J Nucl Med Mol Imaging; 2022 Mar; 66(1):52-60. PubMed ID: 31089075
[TBL] [Abstract][Full Text] [Related]
5. Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.
Ryu SY; Kim MH; Choi SC; Choi CW; Lee KH
J Nucl Med; 2003 Mar; 44(3):347-52. PubMed ID: 12620999
[TBL] [Abstract][Full Text] [Related]
6. HIV status does not have an impact on positron emission tomography-computed tomography (PET-CT) findings or radiotherapy treatment recommendations in patients with locally advanced cervical cancer.
Simonds H; Botha MH; Ellmann A; Warwick J; Doruyter A; Neugut AI; Van Der Merwe H; Jacobson JS
Int J Gynecol Cancer; 2019 Oct; 29(8):1252-1257. PubMed ID: 31413068
[TBL] [Abstract][Full Text] [Related]
7. Impact of combined FDG-PET/CT and MRI on the detection of local recurrence and nodal metastases in thyroid cancer.
Hempel JM; Kloeckner R; Krick S; Pinto Dos Santos D; Schadmand-Fischer S; Boeßert P; Bisdas S; Weber MM; Fottner C; Musholt TJ; Schreckenberger M; Miederer M
Cancer Imaging; 2016 Nov; 16(1):37. PubMed ID: 27809936
[TBL] [Abstract][Full Text] [Related]
8.
Mayoral M; Paredes P; Domènech B; Fusté P; Vidal-Sicart S; Tapias A; Torné A; Pahisa J; Ordi J; Pons F; Lomeña F
Rev Esp Med Nucl Imagen Mol; 2017; 36(1):20-26. PubMed ID: 27667001
[TBL] [Abstract][Full Text] [Related]
9. Limited additional value of cervical ultrasonography over a negative 18F-FDG PET/CT for diagnosing cervical lymph node metastases in patients with esophageal cancer: a systematic review and meta-analysis.
Goense L; Meziani J; van Rossum PSN; Wessels FJ; Meijer GJ; Lam MGEH; van Hillegersberg R; Ruurda JP
Nucl Med Commun; 2018 Jul; 39(7):645-651. PubMed ID: 29672463
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
Driscoll DO; Halpenny D; Johnston C; Sheehy N; Keogan M
Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401
[TBL] [Abstract][Full Text] [Related]
11. Role of 18F-FDG PET/CT in detecting pelvic lymph-node metastases in patients with early-stage uterine cervical cancer: comparison with MRI findings.
Lv K; Guo HM; Lu YJ; Wu ZX; Zhang K; Han JK
Nucl Med Commun; 2014 Dec; 35(12):1204-11. PubMed ID: 25222911
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of pretreatment and after treatment 18F-FDG PET/CT metabolic parameters in patients with locally advanced squamous cell cervical cancer.
Yilmaz B; Dağ S; Ergul N; Çermik TF
Nucl Med Commun; 2019 Mar; 40(3):219-227. PubMed ID: 30585896
[TBL] [Abstract][Full Text] [Related]
13. Patterns of failure after use of (18)F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases.
Chung YL; Horng CF; Lee PI; Chen FL
BMC Cancer; 2016 Mar; 16():179. PubMed ID: 26940959
[TBL] [Abstract][Full Text] [Related]
14. Isolated mediastinal lymph node false positivity of [18F]-fluorodeoxyglucose-positron emission tomography/computed tomography in patients with cervical cancer.
Onal C; Oymak E; Findikcioglu A; Reyhan M
Int J Gynecol Cancer; 2013 Feb; 23(2):337-42. PubMed ID: 23358181
[TBL] [Abstract][Full Text] [Related]
15. (
Scher N; Castelli J; Depeursinge A; Bourhis J; Prior JO; Herrera FG; Ozsahin M
Cancer Radiother; 2018 May; 22(3):229-235. PubMed ID: 29650390
[TBL] [Abstract][Full Text] [Related]
16. F18-FDG-PET/CT in the evaluation of patients with suspected recurrent or persistent locally advanced cervical carcinoma.
Cetina L; Serrano A; Cantú-de-León D; Pérez-Montiel D; Estrada E; Coronel J; Hernández-Lucio M; Dueñas-González A
Rev Invest Clin; 2011; 63(3):227-35. PubMed ID: 21888286
[TBL] [Abstract][Full Text] [Related]
17. Impact of ¹⁸F-FDG PET/CT for detecting recurrence of medullary thyroid carcinoma.
Ozkan E; Soydal C; Kucuk ON; Ibis E; Erbay G
Nucl Med Commun; 2011 Dec; 32(12):1162-8. PubMed ID: 21946617
[TBL] [Abstract][Full Text] [Related]
18. Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT.
Tsai CS; Chang TC; Lai CH; Tsai CC; Ng KK; Hsueh S; Yen TC; Hong JH
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1506-12. PubMed ID: 15050330
[TBL] [Abstract][Full Text] [Related]
19. Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.
Kim YK; Lee KW; Cho SY; Han SS; Kim SH; Kim SK; Park SJ
Liver Transpl; 2010 Jun; 16(6):767-72. PubMed ID: 20517911
[TBL] [Abstract][Full Text] [Related]
20. Detection of Lymph Node Metastasis in Patients with Bladder Cancer using Maximum Standardised Uptake Value and
Vind-Kezunovic S; Bouchelouche K; Ipsen P; Høyer S; Bell C; Bjerggaard Jensen J
Eur Urol Focus; 2019 Jan; 5(1):90-96. PubMed ID: 28753817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
